1. Singapore Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Medinex Ltd.

Medinex Ltd.

SSGX:OTX
0.20
SGD
-0.04
(-16.67%)
30.27MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.01
0.02
0.03
0.09
0.08
0.09
0.1
0.1
0.1
0.09
- -
Basic EPS, GAAP
- -
0.01
0.01
0.01
0.03
0.02
0.01
0.01
0.02
0.02
- -
Free Cash Flow per Basic Share
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.03
0.02
- -
Dividend per Share
- -
0.01
0.01
- -
0.01
0.02
0.01
0.02
0.02
0.02
- -
Book Value per Share
- -
- -
0.05
0.1
0.13
0.13
0.13
0.12
0.13
0.12
0.12
Tangible Book Value per Share
- -
- -
0.03
0.07
0.07
0.08
0.06
0.05
0.06
0.07
0.07
Basic Weighted Avg Shares
104
104
104
98
131
131
132
132
132
133
133
Sales/Revenue/Turnover
1
2
3
9
11
12
13
13
13
12
- -
Operating Margin (%)
57.63
66.13
44.95
33.47
29.21
29.43
29.44
30.15
33.36
33.77
- -
Depreciation Expense
- -
- -
- -
- -
1
1
1
1
1
1
- -
Net Income, GAAP
- -
1
1
1
3
3
2
1
3
2
- -
Effective Tax Rate (%)
4.43
3.84
5.49
22.38
7.85
11.34
17.32
14.66
5.05
8.07
- -
Profit Margin (%)
35.71
42.27
30.92
9.06
32.39
23.41
13.11
8.21
22.12
17.92
- -
Working Capital
- -
- -
4
10
6
6
4
5
5
6
6
LT Debt
- -
- -
- -
- -
3
2
2
1
1
- -
- -
Total Equity
- -
- -
6
14
17
17
18
16
17
17
17
Return on Invested Capital (%)
- -
195.18
36.42
23.41
16.75
15.12
17.25
16.82
20.76
13.42
- -
Return on Capital (%)
- -
139.19
27.12
7.4
20.34
13.48
8.67
6.5
15.73
12.59
- -
Return on Common Equity (%)
- -
223.86
28.94
8.31
23.15
16.56
9.76
6.13
17.27
13.38
- -

Capital Structure

SGD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
133
132
135
Market Capitalization
25
30
30

Working Capital

SGD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
8
7
8
Cash, Cash Equivalents & STI
6
5
6
Accounts Receivable, Net
2
2
2
Inventories
- -
- -
- -
Total Current Liabilities
3
3
2
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-0.37%
-1.24%
Free Cash Flow
- -
-1.26%
-23.34%
Net Income, GAAP
- -
10.9%
-21.53%
Sales/Revenue/Turnover
- -
3.01%
-3.12%
Total Cash Common Dividend
- -
21.08%
0.39%

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
13
2025
- -
- -
13
2026
- -
- -
12

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.01
2025
- -
- -
0.02
2026
- -
- -
0.02

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.02
2025
- -
- -
0.02
2026
- -
- -
0.02

Company Description

Company Profile APIChatGPT
CEO
Mui Choo Low
Full Time Employees
65
Sector
Health services
Industry
Medical/Nursing services
Address
51, Goldhill Plaza Singapore CE Singapore 308900
IPO Date
Dec 7, 2018
Website
medinex.com.sg
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Medinex Limited operates as a medical technology company primarily involved in the manufacturing and distribution of advanced medical devices and healthcare products. The company specializes in producing diagnostic equipment, medical consumables, specialty healthcare products, and rehabilitation devices. Medinex offers a comprehensive range of products including respiratory devices, wound care solutions, diagnostic imaging tools, and telehealth platforms. It services hospitals, clinics, and healthcare providers across key markets in Asia, with a strategic focus on Singapore as its headquarters. Founded in 1998, Medinex has established a robust presence in the medical device industry in the Asia-Pacific region, leveraging technology innovation and comprehensive product offerings to meet diverse healthcare needs. In recent years, Medinex Limited has expanded its business operations through strategic alliances and partnerships with leading global healthcare technology firms, enhancing its product portfolio with integrated digital health and telemedicine solutions. The company has also launched new lines of smart medical devices designed to improve patient monitoring and healthcare delivery in outpatient settings. Additionally, Medinex has bolstered its manufacturing capabilities with updated facilities in Singapore, aimed at supporting increased production volumes and product development. These operational advancements align with its business strategy to penetrate new markets in Southeast Asia and expand service offerings in the telehealth sector. Medinex continues to prioritize innovation and customer-centric solutions in its pursuit of growth and enhanced healthcare accessibility.